SMDPY (Sumitomo Pharma Co) Net Issuance of Preferred Stock : $0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Sumitomo Pharma Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Sumitomo Pharma Co's net issuance of preferred for the three months ended in Sep. 2024 was $0 Mil. The number is 0, which means that Sumitomo Pharma Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Sumitomo Pharma Co's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2024 was $0 Mil.

Sumitomo Pharma Co Net Issuance of Preferred Stock Historical Data

The historical data trend for Sumitomo Pharma Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Net Issuance of Preferred Stock Chart

Sumitomo Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Sumitomo Pharma Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Sumitomo Pharma Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Sumitomo Pharma Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Sumitomo Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:SMDPY) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

DNPUF:USA 4506:Japan DPM:Germany

Address

6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.sumitomo-pharma.com

Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.